| Period | 23 Feb 2012 |
|---|
Media coverage
Media coverage
Title Broadening TDO's base Degree of recognition International Media name/outlet SciBX: Science–Business eXchange Date 23/02/12 URL www.nature.com/scibx/journal/v5/n8/full/scibx.2012.193.html Persons Eduard Dolušić, Raphaël Frederick, Bernard Masereel, Johan Wouters
Related content
-
Research output
-
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Research output: Contribution to journal › Article › peer-review
-
coauthor on lecture: Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase (TDO): discovery of an orally active TDO inhibitor.
Research output: Contribution in Book/Catalog/Report/Conference proceeding › Conference contribution
-
Reversal of Tumoral Immune Resistance by Inhibition of Tryptophan 2,3-Dioxygenase (TDO): Design, Synthesis and Preclinical Evaluation of a Novel TDO Inhibitor.
Research output: Contribution to journal › Literature review › peer-review
-
Tryptophan 2,3-Dioxygenase (TDO) Inhibitors as Anticancer Immunomodulators
Research output: Contribution to conference › Poster
-
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators
Research output: Contribution to journal › Article › peer-review
-
3-ALKENYL INDOLES AS TRYPTOPHAN 2,3-DIOXYGENASE INHIBITORS FOR THE ENHANCEMENT OF CANCER IMMUNOTHERAPY
Research output: Contribution to conference › Poster › peer-review
-
Projects
-
tryptophane 2,3-dioxygénase
Project: Research
-
Press/Media
-
Une avancée considérable contre la cancer
Press/Media: Other
-
AVANCÉE SIGNIFICATIVE DANS LE TRAITEMENT DU CANCER
Press/Media: Research
-
Une avancée belge dans la thérapie du cancer
Press/Media: Other
-
Ogulinac Eduard Dolušić nadomak otkriću lijeka protiv raka
Press/Media: Other
-
Mladi Ogulinac u ekipi koja je na tragu lijeka protiv raka
Press/Media: Other
-
USPJEH MLADOGA OGULINCA
Press/Media: Other
-
Cancer: Des chercheurs namurois innovent.
Press/Media: Other
-
New target for cancer therapy identified, preclinical study shows
Press/Media: Expert Comment
-
Activities
-
BOSS XIII - 13th Belgian Organic Synthesis Symposium Louvain, 15 - 20 juillet 2012
Activity: Participating in or organising an event types › Participation in conference
-
Heterocycles in Bio-organic Chemistry
Activity: Participating in or organising an event types › Participation in conference
-
JFB 2011.
Activity: Participating in or organising an event types › Participation in conference